Topiramate induces type 3 renal tubular acidosis by inhibiting renal carbonic anhydrase.
Sacre, Anne; JOURET, François ; Manicourt, Daniel et al. 2006 • In Nephrology Dialysis Transplantation, 21 (10), p. 2995-6 Peer Reviewed verified by ORBi
DuBose, T.D., Acid-base disorders (2004) The Kidney, pp. 921-996. , In: Brenner BM, ed. Saunders, Philadelphia, USA
Karet, F.E., Inherited distal renal tubular acidosis (2002) J Am Soc Nephrol, 13, pp. 2178-2184
Dodgson, S.J., Shank, R.P., Maryanoff, B.E., Topiramate as an inhibitor of carbonic anhydrase isoenzymes (2000) Epilepsia, 41 (SUPPL. 1), pp. S35-S39
Lehenkari, P., Heutunen, T.A., Laitala-Leinonen, T., Tuukkanen, J., Vaananen, H.K., Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+ (1998) Exp Cell Res, 242, pp. 128-137
Lamb, E.J., Stevens, P.E., Nashef, L., Topiramate increases biochemical risk of nephrolithiasis (2004) Ann Clin Biochem, 41, pp. 166-169
Groeper, K., McCann, M.E., Topiramate and metabolic acidosis: A case series and review of the literature (2005) Paediatr Anaesth, 15, pp. 167-170
